psalexa
logo

Home Infusion Therapy Market

Global Home Infusion Therapy Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10040
Available Format:

Chapter 1. Research Background

1.1. Research Objectives

1.2. Market Definition

1.3. Research Scope

1.3.1. Market Segmentation by Device

1.3.2. Market Segmentation by Application

1.3.3. Market Segmentation by Disease

1.3.4. Market Segmentation by Geography

1.3.5. Analysis Period

1.3.6. Market Data Reporting Unit

1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.2. Primary Research

2.2.1. Breakdown of Primary Research Respondents

2.2.1.1. By region

2.2.1.2. By industry participants

2.2.1.3. By company type

2.3. Market Size Estimation

2.4. Market Breakdown and Data Triangulation

2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Market Segmentation

4.1.1. Overview by Device

4.1.1.1. Infusion Pumps

4.1.1.1.1. Volumetric

4.1.1.1.2. Syringe cotton

4.1.1.1.3. Insulin

4.1.1.1.4. Enteral

4.1.1.1.5. Ambulatory

4.1.1.1.6. Patient-controlled analgesia (PCA)

4.1.1.1.7. Implantable

4.1.1.2. Intravenous Sets

4.1.1.3. Needleless Connectors

4.1.2. Overview by Application

4.1.2.1. Anti-infectives/antibiotics

4.1.2.2. Enteral nutrition

4.1.2.3. Hydration therapy

4.1.2.4. Specialty pharmaceuticals

4.1.2.5. Parenteral nutrition (TPN)

4.1.2.6. Pain management

4.1.2.7. Chemotherapy

4.1.2.8. Others

4.1.3. Overview by Disease

4.1.3.1. Gastrointestinal diseases

4.1.3.2. Cancer

4.1.3.3. Cardiac diseases

4.1.3.4. Diabetes

4.1.3.5. Cystic fibrosis

4.1.3.6. Others

4.2. Market Dynamics

4.2.1. Trends

4.2.2. Drivers

4.2.2.1. Impact analysis of drivers on market forecast

4.2.3. Restraints

4.2.3.1. Impact analysis of restraints on market forecast

4.2.4. Opportunities

4.3. Porter’s Five Forces Analysis

Chapter 5. Market Size and Forecast by Device

5.1. Infusion Pumps

5.1.1. Volumetric

5.1.2. Syringe Cotton

5.1.3. Insulin

5.1.4. Enteral

5.1.5. Ambulatory

5.1.6. Patient-Controlled Analgesia (PCA)

5.1.7. Implantable

5.2. Intravenous Sets

5.3. Needleless Connectors

Chapter 6. Market Size and Forecast by Application

6.1. Anti-Infectives/Antibiotics

6.2. Enteral Nutrition

6.3. Hydration Therapy

6.4. Specialty Pharmaceuticals

6.5. Parenteral Nutrition (TPN)

6.6. Pain Management

6.7. Chemotherapy

6.8. Others

Chapter 7. Market Size and Forecast by Disease

7.1. Gastrointestinal Diseases

7.2. Cancer

7.3. Cardiac Diseases

7.4. Diabetes

7.5. Cystic Fibrosis

7.6. Others

Chapter 8. Market Size and Forecast by Geography

8.1. North America Home Infusion Therapy Market

8.1.1. By Device

8.1.2. By Application

8.1.3. By Disease

8.1.4. By Country – The U.S, and Canada

8.2. Western Europe Home Infusion Therapy Market

8.2.1. By Device

8.2.2. By Application

8.2.3. By Disease

8.2.4. By Country – Germany, Spain, U.K, France, Italy and Rest of Western Europe

8.3. Central and Eastern Europe (CEE) Home Infusion Therapy Market

8.3.1. By Device

8.3.2. By Application

8.3.3. By Disease

8.3.4. By Country – Russia and Rest of CEE

8.4. Asia-Pacific Europe Home Infusion Therapy Market

8.4.1. By Device

8.4.2. By Application

8.4.3. By Disease

8.4.4. By Country – China, Japan, India, Australia and Rest of Asia-Pacific

8.5. Latin America Home Infusion Therapy Market

8.5.1. By Device

8.5.2. By Application

8.5.3. By Disease

8.5.4. By Country – Brazil, Mexico and Rest of Latin America

8.6. Middle East & Africa (MEA) Home Infusion Market

8.6.1. By Device

8.6.2. By Application

8.6.3. By Disease

8.6.4. By Country –South Africa and Rest of MEA

Chapter 9. Competitive Landscape

9.1. Competitive Analysis of Key Players

9.2. Global Strategic Developments

Chapter 10. Company Profiles

10.1. Terumo Corporation

10.1.1. Business Overview

10.1.2. Product and Service Offerings

10.1.3. Key Financial Summary

10.1.4. Strategic Growth Plan

10.2. Baxter International Inc.

10.2.1. Business Overview

10.2.2. Product and Service Offerings

10.2.3. Key Financial Summary

10.2.4. Strategic Growth Plan

10.3. JMS Co. Ltd.

10.3.1. Business Overview

10.3.2. Product and Service Offerings

10.3.3. Key Financial Summary

10.3.4. Strategic Growth Plan

10.4. ICU Medical Inc.

10.4.1. Business Overview

10.4.2. Product and Service Offerings

10.4.3. Key Financial Summary

10.4.4. Strategic Growth Plan

10.5. Becton, Dickinson and Company

10.5.1. Business Overview

10.5.2. Product and Service Offerings

10.5.3. Key Financial Summary

10.5.4. Strategic Growth Plan

10.6. Smiths Group plc.

10.6.1. Business Overview

10.6.2. Product and Service Offerings

10.6.3. Key Financial Summary

10.6.4. Strategic Growth Plan

10.7. Fresenius Kabi AG

10.7.1. Business Overview

10.7.2. Product and Service Offerings

10.7.3. Key Financial Summary

10.7.4. Strategic Growth Plan

10.8. Caesarea Medical Electronics

10.8.1. Business Overview

10.8.2. Product and Service Offerings

10.8.3. Key Financial Summary

10.8.4. Strategic Growth Plan

10.9.  B. Braun Melsungen AG

10.9.1. Business Overview

10.9.2. Product and Service Offerings

10.9.3. Key Financial Summary

10.9.4. Strategic Growth Plan

10.10.  Hospira, Inc.

10.10.1. Business Overview

10.10.2. Product and Service Offerings

10.10.3. Key Financial Summary

10.10.4. Strategic Growth Plan

*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.

Chapter 11. Appendix

11.1. Abbreviations

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry